SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-021391
Filing Date
2024-03-11
Accepted
2024-03-11 16:01:10
Documents
22
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0201525-10ka1_longever.htm   iXBRL 10-K/A 237720
2 CERTIFICATION ea020152501ex31-1_longeveron.htm EX-31.1 9753
3 CERTIFICATION ea020152501ex31-2_longeveron.htm EX-31.2 14071
4 CERTIFICATION ea020152501ex32-1_longeveron.htm EX-32.1 3840
5 CERTIFICATION ea020152501ex32-2_longeveron.htm EX-32.2 4220
10 GRAPHIC image_001.jpg GRAPHIC 1568
11 GRAPHIC image_002.jpg GRAPHIC 1586
12 GRAPHIC image_003.jpg GRAPHIC 1669
  Complete submission text file 0001213900-24-021391.txt   594684

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lgvn-20231231.xsd EX-101.SCH 3235
7 XBRL DEFINITION FILE lgvn-20231231_def.xml EX-101.DEF 19693
8 XBRL LABEL FILE lgvn-20231231_lab.xml EX-101.LAB 39691
9 XBRL PRESENTATION FILE lgvn-20231231_pre.xml EX-101.PRE 20546
23 EXTRACTED XBRL INSTANCE DOCUMENT ea0201525-10ka1_longever_htm.xml XML 9276
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40060 | Film No.: 24737912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)